Toggle light / dark theme

“I realized that in the middle-dose group, which is the one that mattered for the no-effects level, they had conveniently left out one of the two baseline measurement days,” said Sheppard. “The outrageous thing was that the group they declared as NOEL was only that because they left out data from their analysis.” In a peer-reviewed paper published in October 2020, Sheppard and her colleagues concluded that “the omission of valid data without justification was a form of data falsification.”


In any case, bifenthrin was not the only pesticide that dodged testing to see if it presented dangers. The EPA’s pesticide office granted 972 industry requests to waive toxicity tests between December 2011 and May 2018, 89 percent of all requests made. Among the tests on pesticides that were never performed were 90 percent of tests looking for developmental neurotoxicity, 92 percent of chronic cancer studies, and 97 percent of studies looking at how pesticides harm the immune system.

By law, the companies that submit their products for review pay for these tests, and in a presentation about the waivers last year, Anna Lowit, a senior science adviser in the office, emphasized the savings to these companies: more than $300 million. Lowit also noted that animal lives were saved — a goal that the Trump administration and the chemical industry prioritized within the agency. The EPA developed the guidelines for waiving the tests along with BASF, Corteva, and Syngenta, pesticide manufacturers that all stand to benefit significantly from having their products bypass toxicity testing.

There is no replacement for these waived experiments, according to pediatrician and epidemiologist Philip Landrigan. “There is no other way to know if a chemical is toxic but to test it,” said Landrigan, who co-authored a landmark report on children’s particular vulnerability to pesticides. “If they allow chemicals to come onto the market and to be used widely in the environment and put on food crops without testing them for toxicity, then EPA is clearly not fulfilling its mandate to protect human health.”

According to recent Occupational Safety and Health Administration data, workers at Amazon fulfillment centers were seriously injured about twice as often as employees in other warehouses. To improve workplace safety, Amazon has been increasing its investment in robotic helpers to reduce injuries among its employees. With access granted for the first time ever, “Sunday Morning” correspondent David Pogue visited the company’s secret technology facility near Seattle to observe some of the most advanced warehouse robots yet developed, and to experience how high-tech tools are being used to aid human workers.

“CBS Sunday Morning” features stories on the arts, music, nature, entertainment, sports, history, science and Americana, and highlights unique human accomplishments and achievements. Check local listings for CBS Sunday Morning broadcast times.

Get more of “CBS Sunday Morning”: http://cbsn.ws/1PlMmAz.
Follow “CBS Sunday Morning” on Instagram: http://bit.ly/23XunIh.
Like “CBS Sunday Morning” on Facebook: https://bit.ly/3sRgLPG
Follow “CBS Sunday Morning” on Twitter: http://bit.ly/1RquoQb.

Download the CBS News app: http://cbsn.ws/1Xb1WC8

Sanofi will apply Google’s artificial intelligence (AI) and cloud computing capabilities toward developing new drugs, through a collaboration whose value was not disclosed.

The companies said they have agreed to create a virtual Innovation Lab to “radically” transform how future medicines and health services are developed and delivered.

Sanofi has articulated three goals for the collaboration with Google: better understand patients and diseases, increase Sanofi’s operational efficiency, and improve the experience of Sanofi patients and customers.

If concerned, speak to your physician.


In patients with mild cognitive impairment, taking lipophilic statins more than doubles their risk of developing dementia compared to those who do not take statins. According to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting, positron emission tomography (PET) scans of lipophilic statin users revealed a highly significant decline in metabolism in the area of the brain that is first impacted by Alzheimer’s disease.

Statins are medications used to lower cholesterol and reduce the risk of heart attack or stroke. They are the most commonly used drugs in the developed world, and nearly 50 percent of Americans over age 75 use a statin. Different types of statins are available based on a patient’s health needs, including hydrophilic statins that focus on the liver and lipophilic statins that are distributed to tissues throughout the body.

Lipophilic statins include simvastatin, fluvastatin, pitavastatin, lovastatin and atorvastatin. Hydrophilic statins include rosuvastatin and pravastatin.

Exercise and supplements are both great, but if you are constantly feeding your system with home made stimulants that your body produces, you may be fighting an uphill battle. I experienced just that recently, I seemed to be forever on one social media platform or another constantly, under the excuse of promoting my videos, and it really took its toll. So, I just had a few weeks off, reading, exercising, relaxing outside, when the sun was out that is, and going for walks in nature…and now it is your turn. In Attention Span Is Decreasing, I look at how our modern lifestyles, with all their trappings and perks, can have the opposite effect to the one we are after, and how you can start to take back control. Mute alerts, use the flight mode, stick it in a drawer and embrace the 20−5−3 rule, to live not just longer, but happier, and healthier, both in body and mind, because they are inextricably linked. And if you want to know it all in a bit more depth, check out this video on my channel.


In Attention Span Is Decreasing, we will learn how our modern lifestyles, with all their trappings and perks, can have the opposite effect to the one we are…

Still the comic relief til about December 31, 2024. By 2035 curing everything, already in the early stages towards that.


Giovanni Traverso, an MIT assistant professor of mechanical engineering, a gastroenterologist at Brigham and Women’s Hospital, and also the senior author of the study said, that they were actively working on robots that can help provide health care services to maximize the safety, of both the patients and the health care workforce.

Traverso and his colleagues after the Covid-19 began last year, worked towards reducing interaction between the patients and the health care workers. In this process, they collaborated with Boston Dynamics in creating mobile robots that can interact with patients who waited in the emergency department.

But the question here is, how patients are going to respond to the robots? This question was raised by the researchers of MIT along with Brigham and Women’s Hospital. The researchers conducted a nationwide large-scale online survey of about 1000 people working with a market research company called YouGov. The questions were about the acceptability of robots in healthcare for performing tasks like nasal swabs, inserting a catheter, and turning a patient over in bed.

Saccharine, aspartame, sucralose.


New research has discovered that common artificial sweeteners can cause previously healthy gut bacteria to become diseased and invade the gut wall, potentially leading to serious health issues.

The study, published in the International Journal of Molecular Sciences, is the first to show the of some of the most widely used artificial sweeteners—saccharin, sucralose, and aspartame—on two types of gut bacteria, E. coli (Escherichia coli) and E. faecalis (Enterococcus faecalis).

Previous studies have shown that artificial sweeteners can change the number and type of bacteria in the gut, but this new molecular research, led by academics from Anglia Ruskin University (ARU), has demonstrated that sweeteners can also make the bacteria pathogenic. It found that these can attach themselves to, invade, and kill Caco-2 cells, which are that line the wall of the intestine.

The U.S. is facing an unprecedented shortage of obstetricians and gynecologists (OB/GYNs). According to the American College of Obstetricians and Gynecologists, around half of the nation’s counties don’t have access to even a single OB/GYN, which means more than 10 million women are in need of OB/GYNs for primary care. Alarmingly, there are now 8000 fewer women’s health specialists than needed, and that number is predicted rise to 22000 by mid-century.


As the nation’s largest group of Maternal-Fetal Medicine (MFM) and OB/GYN Hospitalist providers, Obstetrix Medical Group is uniquely addressing this critical issue. With multiple diverse TeleMFM programs around the country, Obstetrix provides a key solution for hospitals and community OB/GYN physicians that improves access to specialty care for women with high-risk pregnancies.

Mednax clinicians have long relied on the benefits of telehealth to complement traditional in-person care. MFM providers specifically have utilized various forms of telehealth since the late 1980s. Today, virtual care continues to play an essential role in bridging distance gaps and bringing the highest quality care to patients in need, no matter their location. Through the use Vsee, one of Mednax’s primary telehealth platform vendors, as well as others, clinicians across the country are finding a silver lining during the COVID-19 pandemic. Though helpful in any region, in the rural areas of the Mountain West, it has become even more of a blessing. We spoke with Oliver (Bill) Jones, M.D., about how telehealth integrated into their practice and how it has positively impacted their high-risk patients.

A need for change

Google has invested heavily in healthcare. I think in the end, they will be the ultimate profile provider for users. Just connect your electronic health record with your personal profile combined with Fitbit wearable technologies.


Google has made moves to expand its presence in the healthcare sector during the last 12 months, including multiple partnerships with health systems, several new product launches and efforts to facilitate the country’s COVID-19 vaccine rollout.

Below is a timeline of Google’s key healthcare moves reported by Becker’s Hospital Review since June 2020.

June 18, 2020: Google sister company Verily developed a program to help employees and students safely return to offices and shared spaces while monitoring for COVID-19. The program, dubbed Healthy at Work, is powered by Verily’s software and COVID-19 testing infrastructure.

According to a new study1, an anti-inflammatory protein called interleukin-38, or IL-38, is decreased in the brains of people with autism.

To help protect the brain from injury and infection, the immune cells in the brain, called microglia, usually produce inflammatory molecules2. But it is a tough balance – an inappropriate, or too large, inflammatory response can harm the health of the brain.

Research has shown that there may be changes in the structure and function of microglia in the brains of people with autism. This suggests that atypical inflammatory responses may play a role in autism3, 4, 5.